A World-Class Breast Surgeon in Oregon
Learn why Dr. Jewell is the best choice for your breast surgery.Learn More
- Dr. Mark Jewell honored for editing a peer-reviewed supplement on soft tissue support biomaterials in The Aesthetic Surgery Journal.
- Mark Jewell, M.D. presents body contouring research study at the 50th Annual Meeting of the American Society for Aesthetic Plastic Surgery in San Diego, California.
- A Message To My Patients Regarding Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
- Celebrating BRAve Faces 2016 for Breast Reconstruction Awareness Day
Mark Jewell, M.D. named to Silk Therapeutics Advisory Board.Updated January 22, 2015
Mark Jewell, M.D. of Eugene, OR was named to membership in Silk Therapeutics Advisory Board, January, 2015. Silk Therapeutics (www.silktherapeutics.com ) is based in Medford, MA and offers a broad range of cosmecutical products that utilize solubilized silk proteins. This unique approach to skin care products combines the natural moisturizer and barrier effect of the silk with vitamin C antioxidants.
This is the first time that solubilized silk proteins have been used as a cosmecutical product. Dr. Jewell has worked with the company’s founders, Greg Altman, PhD and Beck Horan, PhD., who developed Seri Surgical Scaffold ®, a FDA-approved, implantable silk-based mesh used for soft tissue support.
This latest development in silk technology originated from research performed under the direction of David Kaplan, PhD-chairman of biomedical engineering, Tufts University, MA. Seri Surgical Scaffold® was a finalist in the 2014 Prix Galien competition for landmark achievement by a new medical device.
Dr. Jewell is honored to be named an advisor to Silk Therapeutics along with other esteemed colleagues.